Pathogenesis of bacterial bronchitis in cystic fibrosis

Pediatric Infectious Disease Journal

Volumn 16, Issue 1, 1997, Pages 91-96

  Smith, Arnold ^a  

^a University of Missouri   (United States)

Author keywords

bacterial; bronchitis; cystic fibrosis; Pathogenesis

Indexed keywords

CHLORIDE CHANNEL; CIPROFLOXACIN;

BACTERIAL COLONIZATION; BRONCHITIS; CONFERENCE PAPER; CYSTIC FIBROSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCOMPETENT CELL; LIFESPAN; PATHOGENESIS; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; TREATMENT PLANNING;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; BRONCHIECTASIS; BRONCHITIS; CYSTIC FIBROSIS; GENE THERAPY; HUMANS; IMMUNOCOMPETENCE; PSEUDOMONAS INFECTIONS;

EID: 0031040975     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199701000-00030     Document Type: Conference Paper

References (14)

1. Tomashefski JF, Abramowsky CR, Dahms BB. The pathology of cystic fibrosis. In: Davis PB, ed. Cystic fibrosis. New York: Marcel Dekker, 1993:435-89.
2. Mearns MB. Natural history of pulmonary infection in cystic fibrosis. In: Sturgess JM, ed. Perspectives in cystic fibrosis. Proceedings of the Eighth International Cystic Fibrosis Congress, Toronto, Canada, May 26 to 30, 1980. Toronto: Canadian Cystic Fibrosis Foundation, 1980:325-34.
3. Knowles MR, Paradiso AM, Boucher RC. In vivo nasal potential difference: techniques and protocols for assessing efficacy of gene transfer in cystic fibrosis. Hum Gene Ther 1995;6: 445-55.
4. Gan KH, Veeze HJ, Ans, MW, et al. A cystic fibrosis mutation associated with mild lung disease. N Engl J Med 1995;333: 95-9.
5. Rose MC. Epithelial mucous glycoproteins and cystic fibrosis. Horm Metab Res 1988;20:601-8.
6. Barasch J, Al-Awqati Q. Defective acidification of the biosynthetic pathway in cystic fibrosis. J Cell Sci 1993;17:229-33.
7. Sanchis J, Dolovich M, Rossman C, Wilson W, Newhouse M. Pulmonary mucociliary clearance in cystic fibrosis. N Engl J Med 1973;288:651-4.
8. Wood RE, Wanner A, Hirsch J, Farrell PM. Tracheal mucociliary transport in patients with cystic fibrosis and its stimulation by terbutaline. Am Rev Respir Dis 1975;111: 733-8.
9. Yeates DB, Sturgess JM, Kahn SR, Levison H, Aspin N. Mucociliary transport in trachea of patients with cystic fibrosis. Arch Dis Child 1976;51:28-33.
10. Rayner CFJ, Rutman A, Dewar A, Cole PJ, Wilson R. Ciliary disorientation in patients with chronic upper respiratory tract inflammation. Am J Respir Crit Care Med 1995;151: 800-4.
11. Penketh A, Pitt T, Roberts D, Hodson M, Batten JC. The relationship of phenotype changes in Pseudomonas aeruginosa to the clinical condition of patients with cystic fibrosis. Am Rev Respir Dis 1983;127:605-8.
12. Koch C, Hoiby N. Pathogenesis of cystic fibrosis. Lancet 1993;341:1065-9.
13. Regelmann WE, Elliott GR, Warwick WJ, Clawson CC. Reduction of sputum Pseudomonas aeruginosa density by antibiotics improves lung function in cystic fibrosis more than do bronchodilators and chest physiotherapy alone. Am Rev Respir Dis 1990;141:914-21.
14. Diver JM, Schollaardt T, Rabin HR, Thorson C, Bryan LE. Persistence mechanisms in Pseudomonas aeruginosa from cystic fibrosis patients undergoing ciprofloxacin therapy. Antimicrob Agents Chemother 1991;35:1538-46.